MedPath

Ortho Development Corporation

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Survivorship and Effectiveness of the Ortho Development® Entrada™ Hip System for Total Hip Arthroplasty

Conditions
Total Hip Replacement
Total Hip Arthroplasty
First Posted Date
2020-02-20
Last Posted Date
2022-10-13
Lead Sponsor
Ortho Development Corporation
Target Recruit Count
250
Registration Number
NCT04277416
Locations
🇺🇸

Oregon Health Sciences University, Portland, Oregon, United States

Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System

Conditions
Osteoarthritis, Hip
Psoriatic Arthritis
Joint Diseases
Rheumatoid Arthritis
Avascular Necrosis of Hip
First Posted Date
2019-06-14
Last Posted Date
2019-06-14
Lead Sponsor
Ortho Development Corporation
Target Recruit Count
400
Registration Number
NCT03986918
Locations
🇺🇸

Straub Medical Center, Honolulu, Hawaii, United States

Balanced Knee System Clinical Protocol for IRB Approval

Not Applicable
Completed
Conditions
Valgus Deformity
Rheumatoid Arthritis of Knee
Osteoarthritis, Knee
Post-traumatic Osteoarthritis of Knee Nos
First Posted Date
2015-02-13
Last Posted Date
2021-09-24
Lead Sponsor
Ortho Development Corporation
Target Recruit Count
500
Registration Number
NCT02362867

News

No news found
© Copyright 2025. All Rights Reserved by MedPath